Beyond C4d: Other complement-related diagnostic approaches to antibody-mediated rejection

被引:59
作者
Baldwin, WM [1 ]
Kasper, EK
Zachary, AA
Wasowska, BA
Rodriguez, ER
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
关键词
antibodies; complement; complement receptors; transplant rejection;
D O I
10.1111/j.1600-6143.2004.00348.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Complement is a multifunctional system of receptors and regulators as well as effector molecules. Both the pathogenic and diagnostic power of complement is based on the capacity of the complement system to amplify innate and adaptive immunity. This amplification is accomplished through two strategies: (1) enzymatic reactions in the complement cascade, and (2) stimulation of leukocytes, platelets and parenchymal cells through specific receptors or receptor-independent pore formation. The mechanisms by which complement mediates and modifies nonspecific inflammation, antibody-mediated injury and T-cell responses are of particular significance to the pathogenesis of transplant rejection. Understanding the mechanisms by which complement integrates the interactions of leukocytes, platelets and parenchymal cells offers opportunities to further refine the diagnosis of rejection.
引用
收藏
页码:311 / 318
页数:8
相关论文
共 69 条
[51]   The pathology of heart transplant biopsy specimens: Revisiting the 1990 ISHLT working formulation [J].
Rodriguez, ER .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (01) :3-15
[52]   von Willebrand factor [J].
Ruggeri, ZM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04) :559-564
[53]   Role of the C5b-9 complement complex in cell cycle and apoptosis [J].
Rus, HG ;
Niculescu, FI ;
Shin, ML .
IMMUNOLOGICAL REVIEWS, 2001, 180 :49-55
[54]   Endothelial cell activation by pore-forming structures -: Pivotal role for interleukin-1α [J].
Saadi, S ;
Holzknecht, RA ;
Patte, CP ;
Platt, JL .
CIRCULATION, 2000, 101 (15) :1867-1873
[55]   COMPLEMENT-MEDIATED REGULATION OF TISSUE FACTOR ACTIVITY IN ENDOTHELIUM [J].
SAADI, S ;
HOLZKNECHT, RA ;
PATTE, CP ;
STERN, DM ;
PLATT, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1807-1814
[56]   Locally produced complement and its role in renal allograft rejection [J].
Sacks, SH ;
Zhou, WD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (08) :927-932
[57]   Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling [J].
Sarwal, M ;
Chua, MS ;
Kambham, N ;
Hsieh, SC ;
Satterwhite, T ;
Masek, M ;
Salvatierra, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :125-138
[58]  
Selvan RS, 1998, J IMMUNOL, V161, P4388
[59]   Complement activation in early protocol kidney graft biopsies after living-donor transplantation [J].
Sund, S ;
Hovig, T ;
Reisaeter, AV ;
Scott, H ;
Bentdal, O ;
Mollnes, TE .
TRANSPLANTATION, 2003, 75 (08) :1204-1213
[60]   The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity [J].
Tedesco, F ;
Pausa, M ;
Nardon, E ;
Introna, M ;
Mantovani, A ;
Dobrina, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) :1619-1627